Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer

Purpose: The RadTox assay measures circulating cell-free DNA released in response to radiotherapy (RT)-induced tissue damage. The primary objectives for this clinical trial were to determine whether cell-free DNA numbers measured by the RadTox assay are (1) correlated with body integral dose, (2) lo...

Full description

Bibliographic Details
Main Authors: Natalie A. Lockney, MD, Randal Henderson, MD, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine Casey-Sawicki, MA, Paul Okunieff, MD
Format: Article
Language:English
Published: Particle Therapy Co-operative Group 2020-09-01
Series:International Journal of Particle Therapy
Subjects:
circulating dna
cell-free dna
protons
prostate cancer
radiation dosimeter
Online Access:https://theijpt.org/doi/pdf/10.14338/IJPT-20-00033.1

Internet

https://theijpt.org/doi/pdf/10.14338/IJPT-20-00033.1

Similar Items